Coley Pharmaceutical Group
Coley Pharmaceutical Group develops therapeutics and drug candidates to fight cancers, asthma, allergy and autoimmune disorders.
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed Coley Pharmaceutical Group Information
Coley Pharmaceutical Group was acquired by
Pfizer.
The acquisition happend on 2007-11-16.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Wellesley
State: Massachusetts
Zip:
Country: United States
Financial Info
Stage:
post ipo equity
Raised Last:
$0
Raised Total:$85M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Coley Pharmaceutical Group operates as a biopharmaceutical company developing therapeutics and drug candidates that direct the human immune system to fight cancers, asthma and allergy, autoimmune disorders, and to enhance the effectiveness of vaccines. The company was formerly known as CpG ImmunoPharmaceuticals, Inc. and in August 2000 it changed its name to Coley Pharmaceutical Group, Inc. The company was founded in 1997 and is based in Wellesley, Massachusetts. As of December 28, 2007, Coley Pharmaceutical Group, Inc. operates as a subsidiary of Pfizer Inc.
Contact Phone:
Contact Email:
Coley Pharmaceutical Group went public on 8/10/2005 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/10/2005
Ticker Symbol:
COLY
IPO Price:
$16/share
Amount Raised:
$84M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2004 | Series G | 2 | $25.2M |
Techno Venture Management Thomas, McNerney &a; Partners Techno Venture Management Thomas, McNerney &a; Partners |
8/1999 | Series B | 3 | $12.9M |
Alafi Capital Techno Venture Management Qiagen Alafi Capital Techno Venture Management |
3/2005 | Venture Round | 1 | $10M |
Pfizer Venture Investments Pfizer Venture Investments |
2/2007 | Post-IPO Equity | 1 | - |
Thuja Capital Thuja Capital |
2/2002 | Series E | 1 | $7M |
Techno Venture Management Techno Venture Management Techno Venture Management Techno Venture Management |
8/2003 | Series F | 4 | $30M |
Global Life Science Ventures Techno Venture Management Thomas, McNerney &a; Partners Venrock Global Life Science Ventures Techno Venture Management Thomas, McNerney &a; Partners Venrock |
2/2007 | Post-IPO Equity | 1 | - |
Thuja Capital Thuja Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
